Form 4: Medifast Director Andrea B. Thomas Receives Stock Units as Part of Deferred Compensation Plan

Director Andrea B. Thomas received 6,596 restricted stock units from Medifast as part of the Director's Deferred Compensation Plan.

Summary

• On June 20, 2024, Andrea B. Thomas, a director of Medifast, Inc., was granted 6,596 restricted stock units.
• These units were awarded under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) as payment for annual director fees.
• Each unit represents the right to receive one share of Medifast's common stock.
• The restricted stock units will vest in full on June 20, 2025.
• Following the transaction, Thomas directly owns 12,849.123 shares of Medifast common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The granting of stock units can be seen as a positive sign of aligning director interests with shareholder value.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The deferred compensation plan allows directors to receive compensation in the form of company stock, potentially incentivizing long-term value creation.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of the stock units in 2025 suggests a continued relationship between the director and the company.

Industry Context

The granting of stock options and restricted stock units is a common practice in corporate governance to align the interests of directors and executives with those of shareholders. This encourages long-term value creation and commitment to the company's success.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity, with the proportion of equity increasing over time to incentivize long-term performance.
• Companies like Herbalife and Nu Skin also utilize stock-based compensation for their directors and executives.
• The vesting schedule of one year is fairly standard for director stock grants.

Stakeholder Impact

• Shareholders may view the granting of stock units positively as it aligns the director's interests with the company's long-term success.
• The director benefits from receiving compensation in the form of company stock, potentially increasing their stake in the company's future performance.

Key Dates